The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Open accessAbstract
The elucidation of breast cancer subgroups and their molecular drivers requires integrated views of the genome and transcriptome from representative numbers of patients. We present an integrated analysis of copy number and gene expression in a discovery and validation set of 997 and 995 primary breast tumours, respectively, with long-term clinical follow-up. Inherited variants (copy number variants and single nucleotide polymorphisms) and acquired somatic copy number aberrations (CNAs) were associated with expression in ~40% of genes, with the landscape dominated by cis- and trans-acting CNAs. By delineating expression outlier genes driven in cis by CNAs, we identified putative cancer genes, including deletions in PPP2R2A, MTAP and MAP2K4. Unsupervised analysis of paired DNA–RNA profiles revealed novel subgroups with distinct clinical outcomes, which reproduced in the validation cohort. These include a high-risk, oestrogen-receptor-positive 11q13/14 cis-acting subgroup and a favourable prognosis subgroup devoid of CNAs. Trans-acting aberration hotspots were found to modulate subgroup-specific gene networks, including a TCR deletion-mediated adaptive immune response in the ‘CNA-devoid’ subgroup and a basal-specific chromosome 5 deletion-associated mitotic network. Our results provide a novel molecular stratification of the breast cancer population, derived from the impact of somatic CNAs on the transcriptome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Currently, numerous research efforts are focused on utilizing genetic data and artificial intelligence algorithms to develop diagnostic models to enhance the clinical efficiency and accuracy of breast cancer diagnosis [109,110,111].”
From A Comprehensive Review on Synergy of Multi-Modal Data and AI Technologies in Medical Diagnosis (2024) · cites this paper as [111]
In the citing paper
“This framework was also employed for a landmark study which used genomic and transcriptomic data from 2,000 breast tumours and discovered novel subgroups amongst them (Curtis et al., 2012).”
From Using machine learning approaches for multi-omics data analysis: A review (2021) · cites this paper as Curtis et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular portraits of human breast tumours
Perou, C., Sørlie, T., Eisen, M., van de Rijn, M., Jeffrey, S., Rees, C. A., Pollack, J., Ross, D., Johnsen, H., Akslen, L., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,551
Self-citationNishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,239
Sørlie, T., Perou, C. M., Tibshirani, R. J., Aas, T., Geisler, S. B., Johnsen, H., Hastie, T. J., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 11,506
Self-citationSupervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Parker, J. S., Mullins, M., Cheang, M. C. U., Leung, S. C. Y., Voduc, D. K., Vickery, T. L., Davies, S. R., Fauron, C. M. ‐., He, X., Hu, Z., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.1370 · Cited by 4,818
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Ki67 expression in breast cancer
Elkablawy, M. A., Albasri, A. M., Mohammed, R. A., Hussainy, A. S., Nouh, M. M., & Alhujaily, A. S. (2016) · Saudi Medical Journal · doi:10.15537/smj.2016.2.12285 · Cited by 4,382
Diagnosis of multiple cancer types by shrunken centroids of gene expression
Tibshirani, R. J., Hastie, T. J., Narasimhan, B., & Chu, G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082099299 · Cited by 2,931
Tumor-Infiltrating CD8+Lymphocytes Predict Clinical Outcome in Breast Cancer
Mahmoud, S., Paish, E. C., Powe, D. G., Macmillan, R. D., Grainge, M. J., Lee, A. H. S., Ellis, I. O., & Green, A. R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.5037 · Cited by 1,411
Self-citationGenomic and transcriptional aberrations linked to breast cancer pathophysiologies
Chin, K., DeVries, S., Fridlyand, J., Spellman, P. T., Roydasgupta, R., Kuo, W.-L., Lapuk, A. V., Neve, R. M., Qian, Z., Ryder, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.009 · Cited by 1,309
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
Jones, S., Wang, T., Shih, I., Mao, T., Nakayama, K., Roden, R. B. S., Glas, R., Slamon, D. J., Diaz, L. A., Vogelstein, B., et al. (2010) · Science · doi:10.1126/science.1196333 · Cited by 1,218
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 1,028
Volinia, S., & Croce, C. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304977110 · Cited by 149
Clinical and molecular complexity of breast cancer metastases
Kimbung, S., Loman, N., & Hedenfalk, I. A. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.08.009 · Cited by 154
Siegel, P. M., Rose, A. A. N., Annis, M. G., & Maric (2013) · OncoTargets and Therapy · doi:10.2147/ott.s44906 · Cited by 150
Deep-learning approach to identifying cancer subtypes using high-dimensional genomic data
Chen, R., Yang, L., Goodison, S., & Sun, Y. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz769 · Cited by 154
Guo, W., Li, H., Zhu, Y., Lan, L., Yang, S., Drukker, K., Morris, E. A., Burnside, E. S., Whitman, G. J., Giger, M. L., et al. (2015) · Journal of Medical Imaging · doi:10.1117/1.jmi.2.4.041007 · Cited by 148
Abdel-Fatah, T. M. A., Russell, R., Albarakati, N., Maloney, D. J., Dorjsuren, D. G., Rueda, O. M., Moseley, P. M., Mohan, V., Sun, H., Abbotts, R., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.04.009 · Cited by 148
Self-citationStromal integrin α11 regulates PDGFRβ signaling and promotes breast cancer progression
Primac, I., Maquoi, E., Blacher, S., Heljäsvaara, R., Deun, J. V., Smeland, H. Y., Canale, A., Louis, T., Stuhr, L. E. B., Sounni, N. E., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125890 · Cited by 155
Tufail, A. B., Ma, Y., Kaabar, M. K. A., Martínez, F., Junejo, A. R., Ullah, I., & Khan, R. (2021) · Computational and Mathematical Methods in Medicine · doi:10.1155/2021/9025470 · Cited by 151
Rodriguez-Ruiz, M. E., Buqué, A., Hensler, M., Chen, J., Bloy, N., Petroni, G., Sato, A., Yamazaki, T., Fucikova, J., & Galluzzi, L. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1655964 · Cited by 147
Notch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy
Abravanel, D. L., Belka, G. K., Pan, T.-C., Pant, D. K., Collins, M. A., Sterner, C. J., & Chodosh, L. A. (2015) · Journal of Clinical Investigation · doi:10.1172/jci74883 · Cited by 147
A computational study of the Warburg effect identifies metabolic targets inhibiting cancer migration
Yizhak, K., Dévédec, S. E. L., Rogkoti, V.-M., Baenke, F., de Boer, V. C. J., Frezza, C., Schulze, A., van de Water, B., & Ruppin, E. (2014) · Molecular Systems Biology · doi:10.15252/msb.20134993 · Cited by 152
A Sox2–Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells
Domenici, G., Aurrekoetxea-Rodríguez, I., Simões, B. M., Rábano, M., Lee, S. Y., Millán, J. S., Comaills, V., Oliemuller, E., López-Ruiz, J. A., Zabalza, I., et al. (2019) · Oncogene · doi:10.1038/s41388-018-0656-7 · Cited by 147
Saha, T., & Lukong, K. E. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.856974 · Cited by 148
Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer
Brown, D. N., Caffa, I., Cirmena, G., Piras, D., Garuti, A., Gallo, M., Alberti, S., Nencioni, A., Ballestrero, A., & Zoppoli, G. M. (2016) · Scientific Reports · doi:10.1038/srep19435 · Cited by 150
Hilton, H. N., Clarke, C. L., & Graham, J. D. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.08.011 · Cited by 158
Poli, V., Fagnocchi, L., Fasciani, A., Cherubini, A., Mazzoleni, S., Ferrillo, S., Miluzio, A., Gaudioso, G., Vaira, V., Turdo, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03264-2 · Cited by 154
Wang, X., Venet, D., Lifrange, F., Larsimont, D., Rediti, M., Stenbeck, L., Dupont, F., Rouas, G., Garcia, A. J., Craciun, L., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54145-w · Cited by 149
Merino, D., Weber, T. S., Serrano, A., Vaillant, F., Liu, K., Pal, B., Di Stefano, L., Schreuder, J., Lin, D., Chen, Y., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08595-2 · Cited by 145
Variational autoencoders for cancer data integration: design principles and computational practice
Simidjievski, N., Bodnar, C., Tariq, I., Scherer, P., Andres Terre, H., Shams, Z., Jamnik, M., & Liò, P. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01205 · Cited by 145
Miller, T. W., & Hosford, S. R. (2014) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s52762 · Cited by 146
Elevated APOBEC3B Correlates with Poor Outcomes for Estrogen-Receptor-Positive Breast Cancers
Sieuwerts, A. M., Willis, S., Burns, M. B., Look, M. P., Gelder, M. E. M., Schlicker, A., Heideman, M. R., Jacobs, H., Wessels, L. F. A., Leyland-Jones, B. R., et al. (2014) · Hormones and Cancer · doi:10.1007/s12672-014-0196-8 · Cited by 145
RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation
Jones, R. A., Robinson, T., Liu, J. C., Shrestha, M., Voisin, V., Ju, Y., Chung, P. E. D., Pellecchia, G., Fell, V. L., Bae, S., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci81568 · Cited by 148
Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers
de Almeida, B. P., Apolónio, J. D., Binnie, A., & Castelo‐Branco, P. (2019) · BMC Cancer · doi:10.1186/s12885-019-5403-0 · Cited by 146
Multi-modality approaches for medical support systems: A systematic review of the last decade
Salvi, M., Loh, H. W., Seoni, S., Barua, P. D., García, S., Molinari, F., & Acharya, U. R. (2024) · Information Fusion · doi:10.1016/j.inffus.2023.102134 · Cited by 144
A Gradient Boosting Algorithm for Survival Analysis via Direct Optimization of Concordance Index
Chen, Y., Jia, Z., Mercola, D., & Xie, X. S. (2013) · Computational and Mathematical Methods in Medicine · doi:10.1155/2013/873595 · Cited by 144
Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199
Schneider, B. P., Li, L., Radovich, M., Shen, F., Miller, K. D., Flockhart, D. A., Jiang, G., Vance, G. H., Gardner, L., Vatta, M., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0586 · Cited by 144
Li, X., Galipeau, P. C., Paulson, T. G., Sanchez, C. A., Arnaudo, J., Liu, K., Sather, C. L., Kostadinov, R. L., Odze, R. D., Kuhner, M. K., et al. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0289 · Cited by 144
Therapeutic Targeting of Integrin αvβ6 in Breast Cancer
Moore, K. M., Thomas, G. J., Duffy, S. W., Warwick, J., Gabe, R., Chou, P., Ellis, I. O., Green, A. R., Haider, S. A., Brouilette, K., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju169 · Cited by 144
Self-citationYY1 regulates cancer cell immune resistance by modulating PD-L1 expression
Hays, E., & Bonavida, B. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.04.001 · Cited by 145
Validation of cluster analysis results on validation data: A systematic framework
Ullmann, T., Hennig, C. M., & Boulesteix, A. (2021) · Wiley Interdisciplinary Reviews Data Mining and Knowledge Discovery · doi:10.1002/widm.1444 · Cited by 157
Clonal fitness inferred from time-series modelling of single-cell cancer genomes
Salehi, S., Kabeer, F., Ceglia, N., Andronescu, M., Williams, M. J., Campbell, K. R., Masud, T., Wang, B., Biele, J., Brimhall, J., et al. (2021) · Nature · doi:10.1038/s41586-021-03648-3 · Cited by 146
Self-citationA Framework for Biobank Sustainability
Watson, P. H., Nussbeck, S. Y., Carter, C., O’Donoghue, S., Cheah, S., Matzke, L. A. M., Barnes, R. O., Bartlett, J. M. S., Carpenter, J. E., Grizzle, W. E., et al. (2014) · Biopreservation and Biobanking · doi:10.1089/bio.2013.0064 · Cited by 143
Self-citationc-Myb Enhances Breast Cancer Invasion and Metastasis through the Wnt/β-Catenin/Axin2 Pathway
Li, Y., Jin, K., van Pelt, G. W., van Dam, H., Xiao, Y., Mesker, W. E., ten Dijke, P., Zhou, F., & Zhang, L. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2302 · Cited by 143
Ivleva, E. I., Clementz, B. A., Dutcher, A. M., Arnold, S. J. M., Jeon‐Slaughter, H., Aslan, S., Witte, B. P., Poudyal, G., Lu, H., Meda, S. A., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.08.030 · Cited by 146
Treatment of advanced HER2-positive breast cancer: 2018 and beyond
Ponde, N. F., Brandão, M., El-Hachem, G., Werbrouck, E., & Piccart, M. J. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.04.016 · Cited by 143
Role of Hedgehog Signaling in Breast Cancer: Pathogenesis and Therapeutics
Galdo, N. A. R., Montero, Á. L., & Wertheimer, E. V. (2019) · Cells · doi:10.3390/cells8040375 · Cited by 145
moCluster: Identifying Joint Patterns Across Multiple Omics Data Sets
Meng, C., Helm, D., Frejno, M., & Küster, B. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00824 · Cited by 147
Mathematical modeling and computational prediction of cancer drug resistance
Sun, X., & Hu, B. X. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx065 · Cited by 142
A survey of neural network-based cancer prediction models from microarray data
Daoud, M., & Mayo, M. (2019) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2019.01.006 · Cited by 141
Structure, Regulation, and Pharmacological Modulation of PP2A Phosphatases
Lambrecht, C., Haesen, D., Sents, W., Ivanova, E., & Janssens, V. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-562-0_17 · Cited by 140
Ortega, C. E., Isaacs, Y. S., & Dominguez, I. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115609 · Cited by 147
Treg depletion potentiates checkpoint inhibition in claudin-low breast cancer
Taylor, N., Vick, S. C., Iglesia, M. D., Brickey, W. J., Midkiff, B. R., McKinnon, K. P., Reisdorf, S., Anders, C. K., Carey, L., Parker, J. S., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90499 · Cited by 140
Geyer, F. C., Li, A., Papanastasiou, A. D., Smith, A. E., Selenica, P., Burke, K. A., Edelweiss, M., Wen, H., Piscuoglio, S., Schultheis, A. M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04128-5 · Cited by 140
Self-citationMRE11 liberates cGAS from nucleosome sequestration during tumorigenesis
Cho, M.-G., Kumar, R. J., Lin, C.-C., Boyer, J. A., Shahir, J. A., Fagan‐Solis, K. D., Simpson, D. A., Fan, C., Foster, C. E., Goddard, A. M., et al. (2024) · Nature · doi:10.1038/s41586-023-06889-6 · Cited by 156
A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy
Srivas, R., Shen, J. P., Yang, C. C., Sun, S. M., Li, J., Gross, A. M., Jensen, J., Licon, K., Bojorquez-Gomez, A., Klepper, K., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.06.022 · Cited by 143
RETRACTED: Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Breast Cancer
Sun, C., Li, S., Hu, W., Zhang, J., Zhou, Q. Y., Liu, C., Li, L., Songyang, Y., Zhang, F., Chen, Z., et al. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.03.019 · Cited by 139
RetractedPearson, A., Proszek, P., Pascual, J., Fribbens, C. V., Shamsher, M. K., Kingston, B., O’Leary, B., Herrera-Abreu, M. T., Cutts, R. J., García-Murillas, I., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-4044 · Cited by 140
Nawaz, S., Heindl, A., Koelble, K., & Yuan, Y. (2015) · Modern Pathology · doi:10.1038/modpathol.2015.37 · Cited by 139
Self-citationDevelopment of a Prognostic Model for Breast Cancer Survival in an Open Challenge Environment
Cheng, W., Yang, T.-H. O., & Anastassiou, D. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005974 · Cited by 138
A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma
Haider, S., Wang, J., Nagano, A., Desai, A., Arumugam, P., Dumartin, L., Fitzgibbon, J., Hagemann, T., Marshall, J. F., Kocher, H. M., et al. (2014) · Genome Medicine · doi:10.1186/s13073-014-0105-3 · Cited by 138
Immune cell infiltration-based signature for prognosis and immunogenomic analysis in breast cancer
Wang, S., Zhang, Q., Yu, C., Cao, Y., Zuo, Y., & Yang, L. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa026 · Cited by 138
A Molecular Portrait of High-Grade Ductal Carcinoma In Situ
Abba, M. C., Gong, T., Lu, Y., Lee, J., Zhong, Y., Lacunza, E., Butti, M., Takata, Y., Gaddis, S., Shen, J., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0506 · Cited by 137
Women at high risk of breast cancer: Molecular characteristics, clinical presentation and management
Kleibl, Z., & Kristensen, V. N. (2016) · The Breast · doi:10.1016/j.breast.2016.05.006 · Cited by 147
The changing role of ER in endocrine resistance
Nardone, A., Angelis, C. D., Trivedi, M. V., Osborne, C. K., & Schiff, R. (2015) · The Breast · doi:10.1016/j.breast.2015.07.015 · Cited by 138
Navigating cancer network attractors for tumor-specific therapy
Creixell, P., Schoof, E. M., Erler, J. T., & Linding, R. (2012) · Nature Biotechnology · doi:10.1038/nbt.2345 · Cited by 136
Piscuoglio, S., Ng, C. K. Y., Murray, M. P., Burke, K. A., Edelweiss, M., Geyer, F. C., Macedo, G. S., Inagaki, A., Papanastasiou, A. D., Martelotto, L. G., et al. (2015) · The Journal of Pathology · doi:10.1002/path.4672 · Cited by 138
Ansari, R. E., Craze, M. L., Miligy, I. M., Diez, M., Nolan, C. C., Ellis, I. O., Rakha, E. A., & Green, A. R. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-0946-6 · Cited by 140
Self-citationGuarducci, C., Bonechi, M., Benelli, M., Biagioni, C., Boccalini, G., Romagnoli, D., Verardo, R., Schiff, R., Osborne, C. K., Angelis, C. D., et al. (2018) · npj Breast Cancer · doi:10.1038/s41523-018-0092-4 · Cited by 140
Dhawan, A., Scott, J. G., Harris, A. L., & Buffa, F. M. (2018) · Nature Communications · doi:10.1038/s41467-018-07657-1 · Cited by 142
The RasGAP Gene, RASAL2, Is a Tumor and Metastasis Suppressor
McLaughlin, S. K., Olsen, S. N., Dake, B. T., Raedt, T. D., Lim, E., Bronson, R. T., Beroukhim, R., Polyák, K., Brown, M. A., Kuperwasser, C., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.004 · Cited by 137
Molecular Homology and Difference between Spontaneous Canine Mammary Cancer and Human Breast Cancer
Liu, D., Xiong, H., Ellis, A. E., Northrup, N. C., Rodriguez, C. O., O'Regan, R. M., Dalton, S., & Zhao, S. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0392 · Cited by 135
Liu, F., Shi, W., Done, S. J., Miller, N. A., Pintilie, M., Voduc, D. K., Nielsen, T. O., Nofech‐Mozes, S., Chang, M. C., Whelan, T. J., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.7999 · Cited by 135
Phenotype-based cell-specific metabolic modeling reveals metabolic liabilities of cancer
Yizhak, K., Gaude, E., Dévédec, S. E. L., Waldman, Y. Y., Stein, G. Y., van de Water, B., Frezza, C., & Ruppin, E. (2014) · eLife · doi:10.7554/elife.03641 · Cited by 140
Wang, J., Kato, F., Oyama‐Manabe, N., Li, R., Cui, Y., Tha, K. K., Yamashita, H., Kudo, K., & Shirato, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143308 · Cited by 138
Green, A. R., Aleskandarany, M. A., Agarwal, D., Elsheikh, S. E., Nolan, C. C., Diez, M., Macmillan, R. D., Ball, G., Caldas, C., Madhusudan, S., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.46 · Cited by 135
Self-citationA framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA
Doebley, A.-L., Ko, M., Liao, H., Cruikshank, A. E., Santos, K., Kikawa, C., Hiatt, J. B., Patton, R. D., Sarkar, N. D., Collier, K. A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35076-w · Cited by 135
Self-citationMultidrug-resistant breast cancer: current perspectives
Tomlinson, D. C., Martin, H. L., & Smith, L. (2014) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s37638 · Cited by 139
Complexities of androgen receptor signalling in breast cancer
McNamara, K. M., Moore, N. L. T., Hickey, T. E., Sasano, H., & Tilley, W. D. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0243 · Cited by 134
Molecular classification of breast cancer: what the pathologist needs to know
Rakha, E. A., & Green, A. R. (2016) · Pathology · doi:10.1016/j.pathol.2016.10.012 · Cited by 134
Self-citationMadden, S. F., Clarke, C., Gaule, P., Aherne, S. T., O’Donovan, N., CLYNES, M. M., Crown, J. P., & Gallagher, W. M. (2013) · Breast Cancer Research · doi:10.1186/bcr3444 · Cited by 135
Variational Bayesian Matrix Factorization for Bounded Support Data
Ma, Z., Teschendorff, A. E., Leijon, A., Qiao, Y., Zhang, H., & Guo, J. H. (2014) · IEEE Transactions on Pattern Analysis and Machine Intelligence · doi:10.1109/tpami.2014.2353639 · Cited by 133
Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling
Junk, D. J., Bryson, B. L., Smigiel, J. M., Parameswaran, N., Bartel, C. A., & Jackson, M. W. (2017) · Oncogene · doi:10.1038/onc.2017.33 · Cited by 133
KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function
Gala, K. P., Li, Q., Sinha, A., Razavi, P., Dorso, M. A., Sánchez-Vega, F., Chung, Y. R., Hendrickson, R. C., Hsieh, J. J.-D., Berger, M. F., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0273-5 · Cited by 137
Bi, M., Zhang, Z., Jiang, Y., Xue, P., Wang, H., Lai, Z., Fu, X., Angelis, C. D., Gong, Y., Gao, Z., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0514-z · Cited by 135
Molecular Classification of Breast Cancer: Relevance and Challenges
Zhang, X. (2022) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2022-0070-ra · Cited by 133
Collateral lethality: a new therapeutic strategy in oncology
Muller, F. L., Aquilanti, E. A., & DePinho, R. A. (2015) · Trends in Cancer · doi:10.1016/j.trecan.2015.10.002 · Cited by 132
Cescon, D. W., Haibe‐Kains, B., & Mak, T. W. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424869112 · Cited by 134
Natrajan, R., Sailem, H., Mardakheh, F. K., Arias-García, M., Tape, C. J., Dowsett, M., Bakal, C., & Yuan, Y. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1001961 · Cited by 134
Self-citationPro-necrotic molecules impact local immunosurveillance in human breast cancer
Stoll, G., Ma, Y., Yang, H., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1299302 · Cited by 137
Mutational Signatures in Breast Cancer: The Problem at the DNA Level
Nik‐Zainal, S., & Morganella, S. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2810 · Cited by 139
Molecular Classification of Breast Cancer
Provenzano, E., Ulaner, G. A., & Chin, S. (2018) · PET Clinics · doi:10.1016/j.cpet.2018.02.004 · Cited by 147
Self-citationA modular master regulator landscape controls cancer transcriptional identity
Paull, E., Aytés, À., Jones, S. J., Subramaniam, P. S., Giorgi, F. M., Douglass, E. F., Tagore, S., Chu, B., Vasciaveo, A., Zheng, S., et al. (2021) · Cell · doi:10.1016/j.cell.2020.11.045 · Cited by 137
Miller, K. D., O’Connor, S., Pniewski, K. A., Kannan, T., Acosta, R., Mirji, G., Papp, S. B., Hulse, M., Mukha, D., Hlavaty, S. I., et al. (2023) · Nature Cancer · doi:10.1038/s43018-023-00636-6 · Cited by 136
Ng, C. K. Y., Martelotto, L. G., Gauthier, A., Wen, H., Piscuoglio, S., Lim, R. S., Cowell, C. F., Wilkerson, P. M., Wai, P. T., Rodrigues, D. N., et al. (2015) · Genome biology · doi:10.1186/s13059-015-0657-6 · Cited by 135
Predicting prognosis and therapeutic response from interactions between lymphocytes and tumor cells
Quigley, D. A., & Kristensen, V. N. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.10.003 · Cited by 132
Allogeneic tumor cell vaccines
Srivatsan, S. R., Patel, J. M., Bozeman, E. N., Imasuen, I., He, S., Daniels, D., & Selvaraj, P. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.26568 · Cited by 133
Pajic, M., Froio, D., Daly, S., Doculara, L., Millar, E. K. A., Graham, P., Drury, A., Steinmann, A. M., de Bock, C. E., Boulghourjian, A., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3105 · Cited by 133
The prognostic effects of somatic mutations in ER-positive breast cancer
Griffith, O. L., Spies, N. C., Anurag, M., Griffith, M., Luo, J. R., Tu, D., Yeo, B. J., Kunisaki, J., Miller, C. A., Krysiak, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05914-x · Cited by 137
MSK1 regulates luminal cell differentiation and metastatic dormancy in ER+ breast cancer
Gawrzak, S., Rinaldi, L., Gregorio, S., Arenas, E. J., Salvador, F., Urosevic, J., Figueras-Puig, C., Rojo, F., Barrantes, I. D. B., Cejalvo, J. M., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-017-0021-z · Cited by 131
Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival
Joseph, C., Alsaleem, M. A., Orah, N., Narasimha, P. L., Miligy, I. M., Kurozumi, S., Ellis, I. O., Mongan, N. P., Green, A. R., & Rakha, E. A. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05670-x · Cited by 131
Self-citationGłodzik, D., Bosch, A., Hartman, J., Aine, M., Vallon‐Christersson, J., Reuterswärd, C., Karlsson, A., Mitra, S., Niméus, E., Holm, K., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17537-2 · Cited by 137
Schulze, A. K., Oshi, M., Endo, I., & Takabe, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218127 · Cited by 133
Single-cell genomic variation induced by mutational processes in cancer
Funnell, T., O’Flanagan, C. H., Williams, M. J., McPherson, A., McKinney, S. E., Kabeer, F., Lee, H., Salehi, S., Vázquez-Garćıa, I., Shi, H., et al. (2022) · Nature · doi:10.1038/s41586-022-05249-0 · Cited by 139
Self-citationMolecular Pathology of Breast Cancer
Allison, K. H. (2012) · American Journal of Clinical Pathology · doi:10.1309/ajcpiv9iq1mrqmoo · Cited by 131
Laine, A., Sihto, H., Come, C., Rosenfeldt, M. T., Zwolinska, A., Niemelä, M., Khanna, A., Chan, E. K., Kähäri, V.-M., Kellokumpu-Lehtinen, P.-L., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0292 · Cited by 130
Hypoxia-induced p53 modulates both apoptosis and radiosensitivity via AKT
Leszczyńska, K. B., Foskolou, I. P., Abraham, A., Anbalagan, S., Tellier, C., Haider, S. A., Span, P. N., O’Neill, E. E., Buffa, F. M., & Hammond, E. M. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80402 · Cited by 135
Tang, H., Sebti, S., Titone, R., Zhou, Y., Isidoro, C., Ross, T. S., Hibshoosh, H. H., Xiao, G., Packer, M., Xie, Y., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.01.008 · Cited by 131
Patten, D. K., Corleone, G., Győrffy, B., Perone, Y., Slaven, N., Barozzi, I., Erdős, E., Saiakhova, A., Goddard, K. S., Vingiani, A., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0091-x · Cited by 134
Greene, L. I., Bruno, T. C., Christenson, J. L., D’Alessandro, A., Culp‐Hill, R., Torkko, K. C., Borges, V. F., Slansky, J. E., & Richer, J. K. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0362 · Cited by 133
TGF-β-induced DACT1 biomolecular condensates repress Wnt signalling to promote bone metastasis
Esposito, M., Cao, F., Cook, K. C., Park, N., Wei, Y., Spadazzi, C., Bracha, D., Gunaratna, R. T., Laevsky, G. S., DeCoste, C. J., et al. (2021) · Nature Cell Biology · doi:10.1038/s41556-021-00641-w · Cited by 133
Metadata
- Authors
- METABRIC Group, Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., Yuan, Y., Gräf, S., Ha, G., Haffari, G., Bashashati, A., Russell, R., McKinney, S., Langerød, A., Green, A., Provenzano, E., Wishart, G., Pinder, S., Watson, P., Markowetz, F., Murphy, L., Ellis, I., Purushotham, A., Børresen-Dale, A.-L., Brenton, J. D., Tavaré, S., Caldas, C., & Aparicio, S.
- Affiliations
- University of Cambridge (GB)
- University of British Columbia (CA)
- Oslo University Hospital (NO)
- University of Nottingham (GB)
- Cambridge University Hospitals NHS Foundation Trust (GB)
- King's College London (GB)
- University of Southern California (US)
- Corresponding author
- Caldas, Carlos
- Aparicio, Samuel
- ORCID
- Curtis, Christina
- Shah, Sohrab P.
- Chin, Suet-Feung
- Turashvili, Gulisa
- Rueda, Oscar M.
- Dunning, Mark J.
- Speed, Doug
- Lynch, Andy G.
- Samarajiwa, Shamith
- Yuan, Yinyin
- Gräf, Stefan
- Ha, Gavin
- Haffari, Gholamreza
- Bashashati, Ali
- Green, Andrew
- Provenzano, Elena
- Wishart, Gordon
- Pinder, Sarah
- Watson, Peter
- Markowetz, Florian
- Murphy, Leigh
- Ellis, Ian
- Purushotham, Arnie
- Brenton, James D.
- Tavaré, Simon
- Caldas, Carlos
- Aparicio, Samuel
- Venue
- Nature
- Published
- 2012-04-18
- Volume
- 486
- Issue
- 7403
- Pages
- 346-352
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3440846
- OpenAlex
- W2005895632
- Cited by
- 6,097
- References
- 32
- Citations by year
- 2026: 341 · 2025: 411 · 2024: 458 · 2023: 497 · 2022: 496 · 2021: 615 · 2020: 533 · 2019: 449 · 2018: 426 · 2017: 361 · 2016: 373 · 2015: 378 · 2014: 339 · 2013: 291 · 2012: 119
- FWCI
- 119.67
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- University of Southern California
- Michael Smith Health Research BC
- Cancer Research UK (A7199, 15601, 19556)
- National Institute for Health and Care Research (ACF-2012-14-006, NF-SI-0611-10154)
- University of Cambridge
- King's College London
- National Institutes of Health
- BC Cancer Agency
- NIHR Cambridge Biomedical Research Centre
- National Human Genome Research Institute (P50-HG02790, P50HG002790)
- Division of Mathematical Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- breast cancer, copy number alterations, somatic copy number alterations, gene expression, single nucleotide polymorphisms, PPP2R2A, MTAP, MAP2K4, estrogen receptor-positive breast cancer, adaptive immune response, basal-like breast cancer, chromosome 5 deletion, molecular stratification, prognosis
- MeSH terms
- Breast Neoplasms, Female, Humans, Prognosis, Genome, Human, Gene Expression Regulation, Neoplastic, Treatment Outcome, Polymorphism, Single Nucleotide, Gene Expression Profiling, Genomics, MAP Kinase Kinase 4, Genes, Neoplasm, Kaplan-Meier Estimate, Gene Regulatory Networks, Protein Phosphatase 2, DNA Copy Number Variations
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
